Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Does reproduction influence epigenetic aging in younger women? April 25, 2024 New approach leverages macrophages to treat traumatic brain injury January 3, 2024 Simple blood test may predict CAR-T therapy success in multiple myeloma July 24, 2024